Heliase Genomics is a synthetic biology company that surveys nature for commercially valuable products.
Heliase Genomics has raised $19K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
Heliase Genomics's investors include Callaghan Innovation.
Heliase Genomics is headquartered in Auckland, New Zealand.
Heliase Genomics is a synthetic biology company that surveys nature for commercially valuable products.
Heliase Genomics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Heliase Genomics — Funding & Investors." VCBacked, August 5, 2021, https://www.vcbacked.co/company/heliase-genomics. Accessed September 30, 2026.
VCBacked. (2021). Heliase Genomics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/heliase-genomics
{{cite web |title=Heliase Genomics — Funding & Investors |url=https://www.vcbacked.co/company/heliase-genomics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated